Breast Cancer Treatment Industry Reviewed in Updated Stakeholder Insights Report Now Available at MarketPublishers.com31 Oct 2011 • by Natalie Aster
LONDON – While some triple-negative breast cancer (TNBC) patients now have an additional treatment option in the form of Avastin, unmet need remains high. Similarly, despite the availability of Herceptin and Tykerb there is also considerable pipeline activity in HER-2-positive breast cancer. At the same time, there is uncertainty over the optimal way of using Herceptin and Tykerb in this patient subset.
Updated market research study “Stakeholder Insight: Breast Cancer (Hormone Receptor-Negative)” prepared by Datamonitor features a complete analysis of the hormone receptor-negative breast cancer market based on a survey of 180 specialists, supported by opinion leader interviews. Epidemiological forecasts of breast cancer incidence and prevalence for the period 2010–19 in the seven major pharmaceutical markets are provided. The report also covers a detailed segmentation of incident cases by age group, menopausal status, stage of disease and subtype, and offers an in-depth analysis of treatment patterns and regimens prescribed for TNBC and HER-2-positive breast cancer by line of therapy and disease stage.
Title: Stakeholder Insight: Breast Cancer (Hormone Receptor-Negative)
Published: November, 2010
Price: US$ 15,200
Scope of the analysis
Datamonitor insight into the hormone receptor-negative breast cancer market
Upcoming related reports
1. INTRODUCTION AND SCOPE
Coverage of the Stakeholder Insight Survey
Introduction and background
Disease definition and diagnosis criteria
Global variation and historical trends
Epidemiologic forecasting of breast cancer
Sources of epidemiologic data
Categorization and stratification
Description of methods
Epidemiologic forecast results
Estimated incident cases and future trends of breast cancer
Segmentation of incident cases: 2010
Estimated prevalent cases
Strengths of our epidemiologic projections
3. DISEASE OVERVIEW
Breast cancer is the most common tumor type in females
Anatomy of the breast
Histology of breast cancer
More new and updated market research reports by the publisher can be found at Datamonitor page.
The Market Publishers, Ltd.
Mrs. Tanya Rezler
Tel: +44 208 123 2220
Fax: +44 207 900 3970